The Role of MicroRNAs in Vitiligo: Regulators and Therapeutic Targets

키워드

참고문헌 (72)

1. Malhotra N, "The pathogenesis of vitiligo", J Cutan Med Surg, 17, pp.153~172 (2013)
2. Solak B, "Effects of age of onset on disease characteristics in non-segmental vitiligo", Int J Dermatol, 56, pp.341~345 (2017)
3. Bronevetsky Y, "Regulation of miRNA biogenesis and turnover in the immune system", Immunol Rev, 253, pp.304~316 (2013)
4. Yao Q, "Emerging roles of microRNAs in the metabolic control of immune cells", Cancer Lett, 433, pp.10~17 (2018)
5. Spritz RA, "Genetics of vitiligo", Dermatol Clin, 35, pp.245~255 (2017)
6. Birlea SA, "Association of generalized vitiligo with MHC class II loci in patients from the Indian subcontinent", J Invest Dermatol, 133, pp.1369~1372 (2013)
7. Jin Y, "Common variants in FOXP1 are associated with generalized vitiligo", Nat Genet, 42, pp.576~578 (2010)
8. Shi YL, "Elevated circulating soluble interleukin-2 receptor in patients with non-segmental vitiligo in North American", J Dermatol Sci, 71, pp.212~214 (2013)
9. Aly DG, "A study of the association of glutathione S-transferase M1", T1 polymorphisms with susceptibility to vitiligo in Egyptian patients, 2018, pp.93, 54~58
10. Karam RA, "Genetic variants of interferon-gamma and its mRNA expression and inflammatory parameters in the pathogenesis of vitiligo", Biochem Cell Biol, 95, pp.474~481 (2017)
11. Song P, "Genetic polymorphism of the Nrf2 promoter region is associated with vitiligo risk in Han Chinese populations", J Cell Mol Med, 20, pp.1840~1850 (2016)
12. Jadeja SD, "A case-control study on association of proteasome subunit beta 8(PSMB8)and transporter associated with antigen processing 1(TAP1)polymorphisms and their transcript levels in vitiligo from Gujarat", PLoS One, 12, pp.e0180958~ (2017)
13. Grill C, "Epidermal melanocytes in segmental vitiligo show altered expression of E-cadherin, but not P-cadherin", Br J Dermatol, 178, pp.1204~1206 (2018)
14. Kim HJ, "Association between polymorphisms of discoidin domain receptor tyrosine kinase 1(DDR1)and non-segmental vitiligo in the Korean population", Eur J Dermatol, 20, pp.231~232 (2010)
15. Almasi-Nasrabadi M, "CDH1 and DDR1 common variants confer risk to vitiligo and autoimmune comorbidities", Gene, 700, pp.17~22 (2019)
16. Mansuri MS, "Genetic variations(Arg5Pro and Leu6Pro)modulate the structure and activity of GPX1 and genetic risk for vitiligo", Exp Dermatol, 25, pp.654~657 (2016)
17. Richmond JM, "Innate immune mechanisms in vitiligo : danger from within", Curr Opin Immunol, 25, pp.676~682 (2013)
18. Li S, "Oxidative stress drives CD8+ T-cell skin trafficking in patients with vitiligo through CXCL16 upregulation by activating the unfolded protein response in keratinocytes", J Allergy Clin Immunol, 140, pp.177~189.e9 (2017)
19. Li S, "Oxidative stress-induced chemokine production mediates CD8(+)T cell skin trafficking in vitiligo", J Investig Dermatol Symp Proc, 17, pp.32~33 (2015)
20. Strassner JP, "Understanding mechanisms of autoimmunity through translational research in vitiligo", Curr Opin Immunol, 43, pp.81~88 (2016)
21. Cavalli G, "MHC class II super-enhancer increases surface expression of HLA-DR and HLA-DQ and affects cytokine production in autoimmune vitiligo", Proc Natl Acad Sci U S A, 113, pp.1363~1368 (2016)
22. Dwivedi M, "Involvement of interferon-gamma genetic variants and intercellular adhesion molecule-1 in onset and progression of generalized vitiligo", J Interferon Cytokine Res, 33, pp.646~659 (2013)
23. Miniati A, "Stimulated human melanocytes express and release interleukin-8, which is inhibited by luteolin:relevance to early vitiligo", Clin Exp Dermatol, 39, pp.54~57 (2014)
24. Ashour AE, "Thymoquinone inhibits growth of human medulloblastoma cells by inducing oxidative stress and caspase-dependent apoptosis while suppressing NF-κB signaling and IL-8 expression", Mol Cell Biochem, 416, pp.141~155 (2016)
25. Iannella G, "Vitiligo: pathogenesis, clinical variants and treatment approaches", Autoimmun Rev, 15, pp.335~343 (2016)
26. Klarquist J, "Functional cloning of a gp100-reactive T-cell receptor from vitiligo patient skin", Pigment Cell Melanoma Res, 29, pp.379~384 (2016)
27. Kovacs D, "Vitiligo : characterization of melanocytes in repigmented skin after punch grafting", J Eur Acad Dermatol Venereol, 29, pp.581~590 (2015)
28. Di Meglio P, "CD8 T Cells and IFN-γ emerge as critical players for psoriasis in a novel model of mouse psoriasiform skin inflammation", J Invest Dermatol, 133, pp.871~874 (2013)
29. Jian Z, "Impaired activation of the Nrf2-ARE signaling pathway undermines H2O2-induced oxidative stress response : a possible mechanism for melanocyte degeneration in vitiligo", J Invest Dermatol, 134, pp.2221~2230 (2014)
30. Thannickal VJ, "Reactive oxygen species in cell signaling", Am J Physiol Lung Cell Mol Physiol, 279, pp.L1005~L1028 (2000)
31. Xie H, "Vitiligo: how do oxidative stress-induced autoantigens trigger autoimmunity?", J Dermatol Sci, 81, pp.3~9 (2016)
32. Manucha W, "Mitochondria and oxidative stress participation in renal inflammatory process", Medicina(B Aires), 74, pp.254~258 (2014)
33. Yi X, "SIRT3-dependent mitochondrial dynamics remodeling contributes to oxidative stress-induced melanocyte degeneration in vitiligo", Theranostics, 9, pp.1614~1633 (2019)
34. Mohammed GF, "Highlights in pathogenesis of vitiligo", World J Clin Cases, 3, pp.221~230 (2015)
35. Basnet B, "Plasma & urinary catecholamines & urinary vanillylmandelic acid levels in patients with generalized vitiligo", Indian J Med Res, 147, pp.384~390 (2018)
36. Sugiura S, "Effect of prolactin-induced protein on human skin : new insight into the digestive action of this aspartic peptidase on the stratum corneum and its induction of keratinocyte proliferation", J Invest Dermatol, 135, pp.776~785 (2015)
37. Mansuri MS, "MicroRNA profiling reveals differentially expressed microRNA signatures from the skin of patients with nonsegmental vitiligo", Br J Dermatol, 171, pp.1263~1267 (2014)
38. Wang Y, "Differential expression analysis of miRNA in peripheral blood mononuclear cells of patients with non-segmental vitiligo", J Dermatol, 42, pp.193~197 (2015)
39. Wang P, "The changes of microRNA expression profiles and tyrosinase related proteins in MITF knocked down melanocytes", Mol Biosyst, 8, pp.2924~2931 (2012)
40. Wu DTs, "Mir-434-5p mediates skin whitening and lightening", Clin Cosmet Investig Dermatol, 1, pp.19~35 (2008)
41. Rambow F, "miR-330-5p targets tyrosinase and induces depigmentation", J Invest Dermatol, 134, pp.2846~2849 (2014)
42. Haflidadóttir BS, "miR-148 regulates Mitf in melanoma cells", PLoS One, 5, pp.e11574~ (2010)
43. Dynoodt P, "Identification of miR-145 as a key regulator of the pigmentary process", J Invest Dermatol, 133, pp.201~209 (2013)
44. Šahmatova L, "MicroRNA-155 is dysregulated in the skin of patients with vitiligo and inhibits melanogenesis-associated genes in melanocytes and keratinocytes", Acta Derm Venereol, 96, pp.742~747 (2016)
45. Dai X, "Regulation of pigmentation by microRNAs : MITF-dependent microRNA-211 targets TGF-β receptor 2", Pigment Cell Melanoma Res, 28, pp.217~222 (2015)
46. Xu C, "The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70and caspase-9 in cardiomyocytes", J Cell Sci, 120(Pt 17), pp.3045~3052 (2007)
47. Shi Q, "Oxidative stress-induced overexpression of miR-25 : the mechanism underlying the degeneration of melanocytes in vitiligo", Cell Death Differ, 23, pp.496~508 (2016)
48. Cui TT, "miR-196a-2 rs11614913 polymorphism is associated with vitiligo by affecting heterodimeric molecular complexes of Tyr and Tyrp1", Arch Dermatol Res, 307, pp.683~692 (2015)
49. Huang Y, "A single-nucleotide polymorphism of miR-196a-2 and vitiligo : an association study and functional analysis in a Han Chinese population", Pigment Cell Melanoma Res, 26, pp.338~347 (2013)
50. Shang Z, "Altered expression of four miRNA (miR1238-3p, miR-202-3p, miR-630 and miR-766-3p) and their potential targets in peripheral blood from vitiligo patients", J Dermatol, 44, pp.1138~1144 (2017)
51. Shi YL, "MicroRNA expression profiling identifies potential serum biomarkers for non-segmental vitiligo", Pigment Cell Melanoma Res, 26, pp.418~421 (2013)
52. Wang Y, "Downregulation of miR-3940-5p promotes T-cell activity by targeting the cytokine receptor IL-2R gamma on human cutaneous T-cell lines", Immunobiology, 221, pp.1378~1381 (2016)
53. Mione M, "MicroRNAs in melanocyte and melanoma biology", Pigment Cell Melanoma Res, 28, pp.340~354 (2015)
54. Mansuri MS, "miRNA signatures and transcriptional regulation of their target genes in vitiligo", J Dermatol Sci, 84, pp.50~58 (2016)
55. Ke K, "MicroRNA-183increases osteoclastogenesis by repressing heme oxygenase-1", Bone, 81, pp.237~246 (2015)
56. Wu Q, "Long noncoding RNA FOXD3-AS1 promotes colon adenocarcinoma progression and functions as a competing endogenous RNA to regulate SIRT1 by sponging miR-135a-5p", J Cell Physiol, 234, pp.21889~21902 (2019)
57. Saunders LR, "miRNAs regulate SIRT1 expression during mouse embryonic stem cell differentiation and in adult mouse tissues", Aging(Albany NY), 2, pp.415~431 (2010)
58. Jiang S, "Molecular dissection of the miR-17-92 cluster’s critical dual roles in promoting Th1 responses and preventing inducible Treg differentiation", Blood, 118, pp.5487~5497 (2011)
59. The Execare Working Group, "Halometasone 0.05% cream in eczematous dermatoses", J Clin Aesthet Dermatol, 6, pp.39~44 (2013)
60. Wong R, "Efficacy of topical calcineurin inhibitors in vitiligo", Int J Dermatol, 52, pp.491~496 (2013)
61. Sisti A, "Effectiveness and safety of topical tacrolimus monotherapy for repigmentation in vitiligo : a comprehensive literature review", An Bras Dermatol, 91, pp.187~195 (2016)
62. Esmat S, "Phototherapy and combination therapies for vitiligo", Dermatol Clin, 35, pp.171~192 (2017)
63. Shafiee A, "The effect of topical piperine combined with narrowband UVB on vitiligo treatment : a clinical trial study", Phytother Res, 32, pp.1812~1817 (2018)
64. Fawzy MM, "Vitiligo-The story from within : a transmission electron microscopic study before and after narrow-band ultraviolet B", Ultrastruct Pathol, 40, pp.265~275 (2016)
65. Fa Y, "Treatment of vitiligo with 308-nm excimer laser : our experience from a 2-year follow-up of 979 Chinese patients", J Eur Acad Dermatol Venereol, 31, pp.337~340 (2017)
66. Wang LM, "Utility of dermoscopy for evaluating the therapeutic efficacy of tacrolimus ointment plus 308-nm excimer laser combination therapy in localized vitiligo patients", Exp Ther Med, 15, pp.3981~3988 (2018)
67. Dillon AB, "Advances in vitiligo : an update on medical and surgical treatments", J Clin Aesthet Dermatol, 10, pp.15~28 (2017)
68. Nahhas AF, "Vitiligo surgery : shuffling melanocytes", J Investig Dermatol Symp Proc, 18, pp.S34~S37 (2017)
69. Gambari R, "Targeting oncomiRNAs and mimicking tumor suppressor miRNAs : new trends in the development of miRNA therapeutic strategies in oncology(Review)", Int J Oncol, 49, pp.5~32 (2016)
70. Maschmeyer P, "Selective targeting of pro-inflammatory Th1 cells by microRNA-148a-specific antagomirs in vivo", J Autoimmun, 89, pp.41~52 (2018)
71. Zhou S, "In vivo therapeutic success of microRNA-155 antagomir in a mouse model of lupus alveolar hemorrhage", Arthritis Rheumatol, 68, pp.953~964 (2016)
72. Su M, "Role of the p53-TRPM1", miR-211-MMP9 axis in UVB-induced human melanocyte migration and its potential in repigmentation, 2020, pp.45, 1017~1026

관련 논문AI추천